Selected research
Industry Research
Bifunctional Epoxide Hydrolase 2 Industry Research Report 2026
Market perspective
The global Bifunctional Epoxide Hydrolase 2 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bifunctional Epoxide Hydrolase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bifunctional Epoxide Hydrolase 2 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bifunctional Epoxide Hydrolase 2 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bifunctional Epoxide Hydrolase 2 include Sumitomo Dainippon Pharma Co., Ltd., GlaxoSmithKline Plc, Toray Industries, Inc. and Sphaera Pharma Pvt. Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bifunctional Epoxide Hydrolase 2 market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bifunctional Epoxide Hydrolase 2 Market by Company
Sumitomo Dainippon Pharma Co., Ltd.
GlaxoSmithKline Plc
Toray Industries, Inc.
Sphaera Pharma Pvt. Ltd.
Bifunctional Epoxide Hydrolase 2 Segment by Type
EC-5026
GSK-2256294
RB-394
Others
Bifunctional Epoxide Hydrolase 2 Segment by Application
Kidney Cancer
Liver Cancer
Lung Cancer
Others
Bifunctional Epoxide Hydrolase 2 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifunctional Epoxide Hydrolase 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bifunctional Epoxide Hydrolase 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifunctional Epoxide Hydrolase 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bifunctional Epoxide Hydrolase 2 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bifunctional Epoxide Hydrolase 2 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bifunctional Epoxide Hydrolase 2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- EC-5026
- GSK-2256294
- RB-394
- Others
Applications
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Others
Companies covered
- Sumitomo Dainippon Pharma Co., Ltd.
- GlaxoSmithKline Plc
- Toray Industries, Inc.
- Sphaera Pharma Pvt. Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bifunctional Epoxide Hydrolase 2 Market Size (2021-2032)
- 2.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales (2021-2032)
- 2.2.3 Global Bifunctional Epoxide Hydrolase 2 Market Average Price (2021-2032)
- 2.3 Bifunctional Epoxide Hydrolase 2 by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 EC-5026
- 2.3.3 GSK-2256294
- 2.3.4 RB-394
- 2.3.5 Others
- 2.4 Bifunctional Epoxide Hydrolase 2 by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Kidney Cancer
- 2.4.3 Liver Cancer
- 2.4.4 Lung Cancer
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bifunctional Epoxide Hydrolase 2 Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bifunctional Epoxide Hydrolase 2 Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Bifunctional Epoxide Hydrolase 2 Revenue of Manufacturers (2021-2026)
- 3.4 Global Bifunctional Epoxide Hydrolase 2 Average Price by Manufacturers (2021-2026)
- 3.5 Global Bifunctional Epoxide Hydrolase 2 Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bifunctional Epoxide Hydrolase 2, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bifunctional Epoxide Hydrolase 2, Product Type & Application
- 3.8 Global Manufacturers of Bifunctional Epoxide Hydrolase 2, Established Date
- 3.9 Global Bifunctional Epoxide Hydrolase 2 Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sumitomo Dainippon Pharma Co., Ltd.
- 4.1.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
- 4.1.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
- 4.1.3 Sumitomo Dainippon Pharma Co., Ltd. Bifunctional Epoxide Hydrolase 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sumitomo Dainippon Pharma Co., Ltd. Bifunctional Epoxide Hydrolase 2 Product Portfolio
- 4.1.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
- 4.2 GlaxoSmithKline Plc
- 4.2.1 GlaxoSmithKline Plc Company Information
- 4.2.2 GlaxoSmithKline Plc Business Overview
- 4.2.3 GlaxoSmithKline Plc Bifunctional Epoxide Hydrolase 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GlaxoSmithKline Plc Bifunctional Epoxide Hydrolase 2 Product Portfolio
- 4.2.5 GlaxoSmithKline Plc Recent Developments
- 4.3 Toray Industries, Inc.
- 4.3.1 Toray Industries, Inc. Company Information
- 4.3.2 Toray Industries, Inc. Business Overview
- 4.3.3 Toray Industries, Inc. Bifunctional Epoxide Hydrolase 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Toray Industries, Inc. Bifunctional Epoxide Hydrolase 2 Product Portfolio
- 4.3.5 Toray Industries, Inc. Recent Developments
- 4.4 Sphaera Pharma Pvt. Ltd.
- 4.4.1 Sphaera Pharma Pvt. Ltd. Company Information
- 4.4.2 Sphaera Pharma Pvt. Ltd. Business Overview
- 4.4.3 Sphaera Pharma Pvt. Ltd. Bifunctional Epoxide Hydrolase 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sphaera Pharma Pvt. Ltd. Bifunctional Epoxide Hydrolase 2 Product Portfolio
- 4.4.5 Sphaera Pharma Pvt. Ltd. Recent Developments
5 Global Bifunctional Epoxide Hydrolase 2 Market Scenario by Region
- 5.1 Global Bifunctional Epoxide Hydrolase 2 Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Region: 2021-2032
- 5.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Region: 2021-2026
- 5.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Region: 2027-2032
- 5.3 Global Bifunctional Epoxide Hydrolase 2 Revenue by Region: 2021-2032
- 5.3.1 Global Bifunctional Epoxide Hydrolase 2 Revenue by Region: 2021-2026
- 5.3.2 Global Bifunctional Epoxide Hydrolase 2 Revenue by Region: 2027-2032
- 5.4 North America Bifunctional Epoxide Hydrolase 2 Market Facts & Figures by Country
- 5.4.1 North America Bifunctional Epoxide Hydrolase 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2032)
- 5.4.3 North America Bifunctional Epoxide Hydrolase 2 Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bifunctional Epoxide Hydrolase 2 Market Facts & Figures by Country
- 5.5.1 Europe Bifunctional Epoxide Hydrolase 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2032)
- 5.5.3 Europe Bifunctional Epoxide Hydrolase 2 Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bifunctional Epoxide Hydrolase 2 Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bifunctional Epoxide Hydrolase 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bifunctional Epoxide Hydrolase 2 Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bifunctional Epoxide Hydrolase 2 Market Facts & Figures by Country
- 5.7.1 South America Bifunctional Epoxide Hydrolase 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2032)
- 5.7.3 South America Bifunctional Epoxide Hydrolase 2 Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Bifunctional Epoxide Hydrolase 2 Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bifunctional Epoxide Hydrolase 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bifunctional Epoxide Hydrolase 2 Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Type (2021-2032)
- 6.1.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Bifunctional Epoxide Hydrolase 2 Sales Market Share by Type (2021-2032)
- 6.2 Global Bifunctional Epoxide Hydrolase 2 Revenue by Type (2021-2032)
- 6.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bifunctional Epoxide Hydrolase 2 Revenue Market Share by Type (2021-2032)
- 6.3 Global Bifunctional Epoxide Hydrolase 2 Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Application (2021-2032)
- 7.1.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Bifunctional Epoxide Hydrolase 2 Sales Market Share by Application (2021-2032)
- 7.2 Global Bifunctional Epoxide Hydrolase 2 Revenue by Application (2021-2032)
- 7.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bifunctional Epoxide Hydrolase 2 Revenue Market Share by Application (2021-2032)
- 7.3 Global Bifunctional Epoxide Hydrolase 2 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bifunctional Epoxide Hydrolase 2 Value Chain Analysis
- 8.1.1 Bifunctional Epoxide Hydrolase 2 Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bifunctional Epoxide Hydrolase 2 Production Mode & Process
- 8.2 Bifunctional Epoxide Hydrolase 2 Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bifunctional Epoxide Hydrolase 2 Distributors
- 8.2.3 Bifunctional Epoxide Hydrolase 2 Customers
9 Global Bifunctional Epoxide Hydrolase 2 Analyzing Market Dynamics
- 9.1 Bifunctional Epoxide Hydrolase 2 Industry Trends
- 9.2 Bifunctional Epoxide Hydrolase 2 Industry Drivers
- 9.3 Bifunctional Epoxide Hydrolase 2 Industry Opportunities and Challenges
- 9.4 Bifunctional Epoxide Hydrolase 2 Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst